Original Research
Published on 04 Aug 2025
JCV-specific cell-based assays for PML risk assessment in lupus and multiple sclerosis patients with and without natalizumab
in Neuroinfectious Diseases
- 359 views
Original Research
Published on 04 Aug 2025
in Neuroinfectious Diseases
Original Research
Published on 04 Aug 2025
in Virology
Original Research
Published on 04 Aug 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 04 Aug 2025
in Computational Genomics
Original Research
Published on 04 Aug 2025
in Neonatology
Original Research
Published on 04 Aug 2025
in Molecular Bacterial Pathogenesis
Review
Published on 04 Aug 2025
in Hepatobiliary Diseases
Original Research
Published on 04 Aug 2025
in Pulmonary Medicine
Original Research
Published on 04 Aug 2025
Original Research
Published on 04 Aug 2025
in AI for Human Learning and Behavior Change
Original Research
Published on 04 Aug 2025
in Animal Behavior and Welfare
Original Research
Published on 04 Aug 2025
in Sustainable Design and Construction
Original Research
Published on 04 Aug 2025
in Solid and Structural Mechanics
Review
Published on 04 Aug 2025
in Sport Psychology
Original Research
Published on 04 Aug 2025
in Experimental Pharmacology and Drug Discovery
Brief Research Report
Published on 04 Aug 2025
in Glaucoma